Market Report Source

Overview

Datamonitor’s Pharmaceuticals Global Industry Guide is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

• Contains an executive summary and data on value, volume and segmentation

• Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies

• Covers Global, European, Asia-Pacific & 11 individual country markets

• Includes a five-year forecast of the industry

Highlights

The global pharmaceuticals market generated total revenues of $555.5 billion in 2006, this representing a compound annual growth rate (CAGR) of 6.6% for the five-year period spanning 2002-2006.

Cardiovascular drug sales proved the most lucrative for the global pharmaceuticals market in 2006, generating total revenues of $106.2 billion, equivalent to 19.1% of the market’s overall value.

The performance of the market is forecast to decelerate, with an anticipated CAGR of 4.8% for the five-year period 2006-2011 expected to drive the market to a value of $703.5 billion by the end of 2011.

Why you should buy this report:

• Spot future trends and developments

• Inform your business decisions

• Add weight to presentations and marketing materials

• Save time carrying out entry-level research

Definition
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2005 annual average exchange rates.

Market shares are for sales in 2005, the most recent full year results available.

For the purpose of this report, the European market is deemed to consist of Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Asia-Pacific consists of Australia, China, India, Japan, Singapore, South Korea and Taiwan.

The Americas consists of the US, Canada, Brazil and Mexico.

The global market consists of Europe, Asia-Pacific and the Americas.

Table of Contents

CHAPTER 1 Introduction

What is this report about?

Who is the target reader?

How to use this report

Definitions

CHAPTER 2 Global Pharmaceuticals

Market Overview

Market Value

Market Segmentation I

Market Segmentation II

Market Share

Competitive Landscape

Market Forecasts

CHAPTER 3 Pharmaceuticals in Asia Pacific

Market Overview

Market Value

Market Segmentation I

Market Segmentation II

Market Share

Competitive Landscape

Market Forecasts

CHAPTER 4 Pharmaceuticals in Europe

Market Overview

Market Value

Market Segmentation I

Market Segmentation II

Market Share

Competitive Landscape

Market Forecasts

Macroeconomic Indicators

CHAPTER 5 Pharmaceuticals in Belgium

Market Overview

Market Value

Market Segmentation I

Market Segmentation II

Market Share

Competitive Landscape

Market Forecasts

Macroeconomic Indicators

CHAPTER 6 Pharmaceuticals in Canada

Market Overview

Market Value

Market Segmentation I

Market Segmentation II

Market Share

Competitive Landscape

Market Forecasts

Macroeconomic Indicators

CHAPTER 7 Pharmaceuticals in China

Market Overview

Market Value

Market Segmentation I

Market Segmentation II

Market Share

Competitive Landscape

Market Forecasts

Macroeconomic Indicators

CHAPTER 8 Pharmaceuticals in France

Market Overview

Market Value

Market Segmentation I

Market Segmentation II

Market Share

Competitive Landscape

Market Forecasts

Macroeconomic Indicators

CHAPTER 9 Pharmaceuticals in Germany

Market Overview

Market Value

Market Segmentation I

Market Segmentation II

Market Share

Competitive Landscape

Market Forecasts

Macroeconomic Indicators

CHAPTER 10 Pharmaceuticals in Italy

Market Overview

Market Value

Market Segmentation I

Market Segmentation II

Market Share

Competitive Landscape

Market Forecasts

Macroeconomic Indicators

CHAPTER 11 Pharmaceuticals in Japan

Market Overview

Market Value

Market Segmentation I

Market Segmentation II

Market Share

Competitive Landscape

Market Forecasts

Macroeconomic Indicators

CHAPTER 12 Pharmaceuticals in the Netherlands

Market Overview

Market Value

Market Segmentation I

Market Segmentation II

Market Share

Competitive Landscape

Market Forecasts

Macroeconomic Indicators

CHAPTER 13 Pharmaceuticals in Spain

Market Overview

Market Value

Market Segmentation I

Market Segmentation II

Market Share

Competitive Landscape

Market Forecasts

Macroeconomic Indicators

CHAPTER 14 Pharmaceuticals in the United Kingdom

Market Overview

Market Value

Market Segmentation I

Market Segmentation II

Market Share

Competitive Landscape

Market Forecasts

Macroeconomic Indicators

CHAPTER 15 Pharmaceuticals in the United States

Market Overview

Market Value

Market Segmentation I

Market Segmentation II

Market Share

Competitive Landscape

Market Forecasts

Macroeconomic Indicators

CHAPTER 16 Company Profiles

GlaxoSmithKline Plc

Pfizer Inc

Sanofi-Aventis Group

CHAPTER 17 Appendix

Data Research Methodology

Report writing team

List of Tables

Table 1: Global Pharmaceuticals Market Value: $ billion, 2002-2006

Table 2: Global Pharmaceuticals Market Segmentation I: % Share, by Value, 2005

Table 3: Global Pharmaceuticals Market Segmentation II: % Share, by Value, 2006

Table 4: Global Pharmaceuticals Market Share: % Share, by Value, 2005

Table 5: Global Pharmaceuticals Market Value Forecast: $ billion, 2006-2011

Table 6: Asia-Pacific Pharmaceuticals Market Value: $ billion, 2002-2006

Table 7: Asia-Pacific Pharmaceuticals Market Segmentation I: % Share, by Value, 2006

Table 8: Asia-Pacific Pharmaceuticals Market Segmentation II: % Share, by Value, 2005

Table 9: Asia-Pacific Pharmaceuticals Market Share: % Share, by Value, 2005

Table 10: Asia-Pacific Pharmaceuticals Market Value Forecast: $ billion, 2006-2011

Table 11: Europe Pharmaceuticals Market Value: $ billion, 2002-2006

Table 12: Europe Pharmaceuticals Market Segmentation I: % Share, by Value, 2006

Table 13: Europe Pharmaceuticals Market Segmentation II: % Share, by Value, 2006

Table 14: Europe Pharmaceuticals Market Share: % Share, by Value, 2005

Table 15: Europe Pharmaceuticals Market Value Forecast: $ billion, 2006-2011

Table 16: Europe Exchange Rate, 2002

Table 17: Belgium Pharmaceuticals Market Value: $ billion, 2002-2006

Table 18: Belgium Pharmaceuticals Market Segmentation I: % Share, by Value, 2006

Table 19: Belgium Pharmaceuticals Market Segmentation II: % Share, by Value, 2006

Table 20: Belgium Pharmaceuticals Market Share: % Share, by Value, 2005

Table 21: Belgium Pharmaceuticals Market Value Forecast: $ billion, 2006-2011

Table 22: Belgium Size of Population (million) , 2002-2006

Table 23: Belgium GDP (1995=100), 2002-2006

Table 24: Belgium Exchange Rate, 2002

Table 25: Canada Pharmaceuticals Market Value: $ billion, 2002-2006

Table 26: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2006

Table 27: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2005

Table 28: Canada Pharmaceuticals Market Share: % Share, by Value, 2005

Table 29: Canada Pharmaceuticals Market Value Forecast: $ billion, 2006-2011

Table 30: Canada Size of Population (million) , 2002-2006

Table 31: Canada GDP (1995=100), 2002-2006

Table 32: Canada Inflation, 2002-2006

Table 33: Canada Exchange Rate, 2002

Table 34: China Pharmaceuticals Market Value: $ billion, 2002-2006

Table 35: China Pharmaceuticals Market Segmentation I: % Share, by Value, 2006

Table 36: China Pharmaceuticals Market Segmentation II: % Share, by Value, 2006

Table 37: China Pharmaceuticals Market Share: % Share, by Value, 2005

Table 38: China Pharmaceuticals Market Value Forecast: $ billion, 2006-2011

Table 39: China Size of Population (million) , 2002-2006

Table 40: China GDP (1995=100), 2002-2006

Table 41: China Inflation, 2002-2006

Table 42: China Exchange Rate, 2002

Table 43: France Pharmaceuticals Market Value: $ billion, 2002-2006

Table 44: France Pharmaceuticals Market Segmentation I: % Share, by Value, 2006

Table 45: France Pharmaceuticals Market Segmentation II: % Share, by Value, 2006

Table 46: France Pharmaceuticals Market Share: % Share, by Value, 2005

Table 47: France Pharmaceuticals Market Value Forecast: $ billion, 2006-2011

Table 48: France Size of Population (million) , 2002-2006

Table 49: France GDP (1995=100), 2002-2006

Table 50: France Inflation, 2002-2006

Table 51: France Exchange Rate, 2002

Table 52: Germany Pharmaceuticals Market Value: $ billion, 2002-2006

Table 53: Germany Pharmaceuticals Market Segmentation I: % Share, by Value, 2006

Table 54: Germany Pharmaceuticals Market Segmentation II: % Share, by Value, 2006

Table 55: Germany Pharmaceuticals Market Share: % Share, by Value, 2005

Table 56: Germany Pharmaceuticals Market Value Forecast: $ billion, 2006-2011

Table 57: Germany Size of Population (million) , 2002-2006

Table 58: Germany GDP (1995=100), 2002-2006

Table 59: Germany Inflation, 2002-2006

Table 60: Germany Exchange Rate, 2002

Table 61: Italy Pharmaceuticals Market Value: $ billion, 2002-2006

Table 62: Italy Pharmaceuticals Market Segmentation I: % Share, by Value, 2006

Table 63: Italy Pharmaceuticals Market Segmentation II: % Share, by Value, 2006

Table 64: Italy Pharmaceuticals Market Share: % Share, by Value, 2005

Table 65: Italy Pharmaceuticals Market Value Forecast: $ billion, 2006-2011

Table 66: Italy Size of Population (million) , 2002-2006

Table 67: Italy GDP (1995=100), 2002-2006

Table 68: Italy Inflation, 2002-2006

Table 69: Italy Exchange Rate, 2002

Table 70: Japan Pharmaceuticals Market Value: $ billion, 2002-2006

Table 71: Japan Pharmaceuticals Market Segmentation I: % Share, by Value, 2006

Table 72: Japan Pharmaceuticals Market Segmentation II: % Share, by Value, 2006

Table 73: Japan Pharmaceuticals Market Share: % Share, by Value, 2005

Table 74: Japan Pharmaceuticals Market Value Forecast: $ billion, 2006-2011

Table 75: Japan Size of Population (million) , 2002-2006

Table 76: Japan GDP (1995=100), 2002-2006

Table 77: Japan Exchange Rate, 2002

Table 78: Netherlands Pharmaceuticals Market Value: $ billion, 2002-2006

Table 79: Netherlands Pharmaceuticals Market Segmentation I: % Share, by Value, 2006

Table 80: Netherlands Pharmaceuticals Market Segmentation II: % Share, by Value, 2006

Table 81: Netherlands Pharmaceuticals Market Share: % Share, by Value, 2005

Table 82: Netherlands Pharmaceuticals Market Value Forecast: $ billion, 2006-2011

Table 83: Netherlands Size of Population (million) , 2002-2006

Table 84: Netherlands GDP (1995=100), 2002-2006

Table 85: Netherlands Exchange Rate, 2002

Table 86: Spain Pharmaceuticals Market Value: $ billion, 2002-2006

Table 87: Spain Pharmaceuticals Market Segmentation I: % Share, by Value, 2006

Table 88: Spain Pharmaceuticals Market Segmentation II: % Share, by Value, 2006

Table 89: Spain Pharmaceuticals Market Share: % Share, by Value, 2005

Table 90: Spain Pharmaceuticals Market Value Forecast: $ billion, 2006-2011

Table 91: Spain Size of Population (million) , 2002-2006

Table 92: Spain GDP (1995=100), 2002-2006

Table 93: Spain Inflation, 2002-2006

Table 94: Spain Exchange Rate, 2002

Table 95: United Kingdom Pharmaceuticals Market Value: $ billion, 2002-2006

Table 96: United Kingdom Pharmaceuticals Market Segmentation I: % Share, by Value, 2006

Table 97: United Kingdom Pharmaceuticals Market Segmentation II: % Share, by Value, 2006

Table 98: United Kingdom Pharmaceuticals Market Share: % Share, by Value, 2005

Table 99: United Kingdom Pharmaceuticals Market Value Forecast: $ billion, 2006-2011

Table 100: United Kingdom Size of Population (million) , 2002-2006

Table 101: United Kingdom GDP (1995=100), 2002-2006

Table 102: United Kingdom Inflation, 2002-2006

Table 103: United Kingdom Exchange Rate, 2002

Table 104: United States Pharmaceuticals Market Value: $ billion, 2002-2006

Table 105: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2006

Table 106: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2006

Table 107: United States Pharmaceuticals Market Share: % Share, by Value, 2005

Table 108: United States Pharmaceuticals Market Value Forecast: $ billion, 2006-2011

Table 109: United States Size of Population (million) , 2002-2006

Table 110: United States GDP (1995=100), 2002-2006

Table 111: United States Inflation, 2002-2006

Table 112: Key Facts

Table 113: SWOT Analysis

Table 114: Key Facts